Lantz Financial LLC Merck & Co., Inc. Transaction History

Lantz Financial LLC

$351 Million
Q3 2024

A detailed history of Lantz Financial LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lantz Financial LLC holds 14,506 shares of MRK stock, worth $1.4 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

14,506

Previous 14,500 0.04%

Holding current value

$1.4 Million

Previous $1.8 Million 8.25%

% of portfolio

0.47%

Previous 0.58%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$111.15 - $128.97 $666 - $773	6 Added 0.04%	14,506 $1.65 Million
Q2 2024 Jul 10, 2024	BUY	$123.8 - $132.96 $5,199 - $5,584	42 Added 0.29%	14,500 $1.8 Million
Q1 2024 Apr 10, 2024	BUY	$113.24 - $131.95 $1,358 - $1,583	12 Added 0.08%	14,458 $1.91 Million
Q4 2023 Jan 12, 2024	BUY	$100.18 - $109.02 $237,927 - $258,922	2,375 Added 19.68%	14,446 $1.57 Million
Q3 2023 Oct 20, 2023	BUY	$102.95 - $114.33 $9,059 - $10,061	88 Added 0.73%	12,071 $1.24 Million
Q2 2023 Jul 12, 2023	SELL	$108.61 - $118.38 $30,302 - $33,028	-279 Reduced 2.28%	11,983 $1.38 Million
Q1 2023 Apr 10, 2023	SELL	$102.94 - $114.86 $67,734 - $75,577	-658 Reduced 5.09%	12,262 $1.3 Million
Q4 2022 Jan 23, 2023	SELL	$87.44 - $112.11 $22,209 - $28,475	-254 Reduced 1.93%	12,920 $0
Q3 2022 Oct 17, 2022	SELL	$84.53 - $94.96 $37,615 - $42,257	-445 Reduced 3.27%	13,174 $1.14 Million
Q2 2022 Jul 29, 2022	SELL	$83.49 - $94.64 $55,687 - $63,124	-667 Reduced 4.67%	13,619 $1.24 Million
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $50,354 - $56,444	685 Added 5.04%	14,286 $1.17 Million
Q4 2021 Jan 19, 2022	SELL	$72.28 - $90.54 $16,479 - $20,643	-228 Reduced 1.65%	13,601 $1.04 Million
Q3 2021 Oct 14, 2021	BUY	$71.68 - $78.83 $35,911 - $39,493	501 Added 3.76%	13,829 $1.04 Million
Q2 2021 Jul 16, 2021	BUY	$70.31 - $77.77 $101,105 - $111,833	1,438 Added 12.09%	13,328 $1.04 Million
Q1 2021 Apr 19, 2021	BUY	$68.86 - $81.11 $5,371 - $6,326	78 Added 0.66%	11,890 $917,000
Q4 2020 Jan 19, 2021	SELL	$71.77 - $79.65 $755,953 - $838,953	-10,533 Reduced 47.14%	11,812 $966,000
Q3 2020 Oct 09, 2020	BUY	$73.18 - $82.95 $26,198 - $29,696	358 Added 1.63%	22,345 $1.85 Million
Q2 2020 Jul 22, 2020	SELL	$70.42 - $80.13 $474,419 - $539,835	-6,737 Reduced 23.45%	21,987 $1.7 Million
Q1 2020 Apr 10, 2020	BUY	$63.36 - $87.82 $657,360 - $911,132	10,375 Added 56.54%	28,724 $2.21 Million
Q4 2019 Jan 17, 2020	BUY	$77.58 - $87.54 $5,197 - $5,865	67 Added 0.37%	18,349 $1.67 Million
Q3 2019 Oct 18, 2019	BUY	$76.08 - $82.93 $76 - $82	1 Added 0.01%	18,282 $1.49 Million
Q2 2019 Jul 15, 2019	SELL	$69.84 - $81.59 $77,382 - $90,401	-1,108 Reduced 5.71%	18,281 $1.56 Million
Q1 2019 Apr 22, 2019	BUY	$69.58 - $79.36 $1.35 Million - $1.54 Million	19,389 New	19,389 $1.61 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantz Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantz Financial LLC with notifications on news.

Account

Lantz Financial LLC Merck & Co., Inc. Transaction History